MICHELLE DIGIOVANNI: Open Payments
NPI 1891932703 · TURLOCK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 15 payments from 15 companies in 2025. Trend: 2023 $688 · 2024 $267 · 2025 $393
Food & beverage: $294Education: $99
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| Geron Corporation | 1 | $30 |
| SERVIER PHARMACEUTICALS LLC | 1 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $20 |
| Celgene Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: FOTIVDA, RYTELO, Voranigo, VERZENIO, RYBREVANT, IMBRUVICA, Orserdu, QINLOCK.
Industry payments across CA — which companies pay providers there.
